Sign inGet started

Maris William J

Insider CIK 1722210 · ASNS 10% owner · HLTH 10% owner · FULC 10% owner · DAVE 10% owner · DALS Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
DAVE Dave Inc./DE S Sale2024-10-092024-10-111,000,000$40.60 $40.60M1,028,232SEC↗
DAVE Dave Inc./DE S Sale2024-05-102024-05-14110,000$48.90 $5.38M2,028,232SEC↗
DAVE Dave Inc./DE S Sale2024-05-072024-05-09450,000$48.90 $22.00M2,138,232SEC↗
DAVE Dave Inc./DE S Sale2023-08-082023-08-10297,771$5.73 $1.71M2,588,232SEC↗
DAVE Dave Inc./DE S Sale2022-09-302022-10-0497,300$0.36 $35.0K92,352,107SEC↗
DAVE Dave Inc./DE S Sale2022-09-292022-09-29400,974$0.35 $140.3K92,449,407SEC↗
DAVE Dave Inc./DE S Sale2022-09-282022-09-29248,782$0.42 $104.5K92,850,381SEC↗
DAVE Dave Inc./DE S Sale2022-09-272022-09-2998,364$0.44 $43.3K93,099,163SEC↗
DAVE Dave Inc./DE S Sale2022-09-152022-09-1924,181$0.50 $12.1K93,197,527SEC↗
DAVE Dave Inc./DE S Sale2022-09-132022-09-1418,181$0.51 $9.3K93,221,708SEC↗
DAVE Dave Inc./DE S Sale2022-09-122022-09-1465,133$0.53 $34.5K93,239,889SEC↗
DAVE Dave Inc./DE S Sale2022-08-152022-08-162,094,168$0.61 $1.28M93,305,022SEC↗
DAVE Dave Inc./DE S Sale2022-08-122022-08-16656,654$0.66 $433.4K95,399,190SEC↗
DAVE Dave Inc./DE S Sale2022-08-102022-08-10361,633$0.74 $267.6K96,055,844SEC↗
DAVE Dave Inc./DE S Sale2022-08-092022-08-101,380,045$0.76 $1.05M96,417,477SEC↗
DAVE Dave Inc./DE S Sale2022-08-082022-08-10317,404$0.77 $244.4K97,797,522SEC↗
DAVE VPC Impact Acquisition Hol A Award2022-01-052022-01-0798,114,926— $098,114,926SEC↗
HLTH Cue Health Inc. C Conversion deriv2021-09-282021-09-303,485,535— $00SEC↗
HLTH Cue Health Inc. C Conversion2021-09-282021-09-303,485,535— $03,485,535SEC↗
DALS DA32 Life Science Tech Acq D To issuer deriv2021-08-052021-08-0930,000— $04,665,000SEC↗
DALS DA32 Life Science Tech Acq D To issuer deriv2021-08-052021-08-09701,250— $04,695,000SEC↗
DALS DA32 Life Science Tech Acq A Award2021-07-302021-08-03650,000$10.00 $6.50M1,450,000SEC↗
DALS DA32 Life Science Tech Acq P Buy2021-07-302021-08-03800,000$10.00 $8.00M800,000SEC↗
FULC Fulcrum Therapeutics, Inc. C Conversion deriv2019-07-222019-07-223,250,000— $00SEC↗
FULC Fulcrum Therapeutics, Inc. C Conversion2019-07-222019-07-22464,285— $0464,285SEC↗
ASNS Arsanis, Inc. C Conversion deriv2017-11-202017-11-201,540,500— $00SEC↗
ASNS Arsanis, Inc. C Conversion2017-11-202017-11-20451,362— $0451,362SEC↗